Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Accounting Officer
-
Issuer Symbol
-
KRYS on Nasdaq
Kathryn Romano - trading volume in the past year for Krystal Biotech, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
18,568 |
$5,420,556 |
$291.93 |
09 Feb 2026 |
Direct |
|
|
| Performance Stock Units |
7,500 |
$1,322,925 |
$176.39 |
28 Feb 2025 |
Direct |
Common Stock |
|
| Restricted Stock Units |
2,200 |
$388,058 |
$176.39 |
28 Feb 2025 |
Direct |
Common Stock |
|
| Stock Option (Right to Buy) |
12,500 |
|
|
09 Feb 2026 |
Direct |
Common Stock |
|
Transactions reported by Kathryn Romano for Krystal Biotech, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.